Vertiflex’s Superion Interspinous Spacer Gets FDA Panel Date
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Orthopaedic and Rehabilitation Devices Panel will meet in December to consider Vertiflex’s submission to support approval of the Superion interspinous spacer to treat moderate lumbar spinal stenosis.